Online citations, reference lists, and bibliographies.
← Back to Search

Self-assembled Hyaluronate/protamine Polyelectrolyte Nanoplexes: Synthesis, Stability, Biocompatibility And Potential Use As Peptide Carriers.

A. Umerska, K. Paluch, María-José Martínez, O. Corrigan, Carlos Medina, L. Tajber
Published 2014 · Medicine, Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
This work investigates a new type of polyelectrolyte complex nanocarrier composed of hyaluronic acid (HA) and protamine (PROT). Small (approximately 60 nm) and negatively charged nanoparticles (NPs) with a polydispersity index of less than 0.2 were obtained with properties that were dependent on the mixing ratio, concentration of polyelectrolytes and molecular weight of HA. Salmon calcitonin (sCT) was efficiently (up to 100%) associated with the NPs, and the drug loading (9.6-39% w/w) was notably high, possibly due to an interaction between HA and sCT. The NPs released -70-80% of the sCT after 24 hours, with the estimated total amount of released sCT depending on the amount of HA and PROT present in the NPs. The isoelectric point of the NPs was close to pH 2, and the negative surface charge was maintained above this pH. The HA/PROT nanoplexes protected the sCT from enzymatic degradation and showed low toxicity to intestinal epithelial cells, and thus may be a promising oral delivery system for peptides.
This paper references
10.1002/CHIN.199912338
Hyaluronan: Preparation, Structure, Properties, and Applications
Lubomic Lapcik (1999)
10.2147/IJN.S8692
Preparation and characterization of low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as FGF-2 carrier
Y. Mori (2010)
a review of its capabilities in pharmacological modeling, Fundam
S. Goutelle (2008)
10.1006/ABBI.1994.1134
Binding properties of glycosaminoglycans to lysozyme--effect of salt and molecular weight.
M. van Damme (1994)
10.1016/j.ejpb.2011.04.008
A new drug nanocarrier consisting of polyarginine and hyaluronic acid.
F. Oyarzun-Ampuero (2011)
10.1111/j.2042-7158.2012.01539.x
Impact of process variables on the micromeritic and physicochemical properties of spray‐dried porous microparticles, part I: introduction of a new morphology classification system
K. Paluch (2012)
10.1002/mabi.200700190
Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules.
M. de la Fuente (2008)
10.1016/S0378-5173(02)00631-2
In vitro evaluation of polymeric excipients protecting calcitonin against degradation by intestinal serine proteases.
D. Guggi (2003)
10.1016/j.ijpharm.2010.07.001
Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin.
Abdallah Makhlof (2010)
10.1021/BM049786+
Versatile and efficient formation of colloids of biopolymer-based polyelectrolyte complexes.
C. Schatz (2004)
10.1002/adma.200903790
Engineering nanoassemblies of polysaccharides.
Soheil Boddohi (2010)
Salmon calcitoninloaded Eudragit ® and Eudragit ®PLGA nanoparticles : in vitro and in vivo evaluation
M. S. Aktas (2010)
introduction of a new morphology classification system, J
K. J. Paluch (2012)
10.1088/0957-4484/19/7/075105
Design of novel polysaccharidic nanostructures for gene delivery.
M. de la Fuente (2008)
protamine sulfate causes drastic size reduction, J
G. Mayer (2005)
10.1016/J.IJBIOMAC.2005.11.010
Preparation and characterization of biocompatible polyelectrolyte complex multilayer of hyaluronic acid and poly-L-lysine.
S. Hahn (2005)
10.1016/j.ejps.2009.04.004
Quantifying drug release from PLGA nanoparticulates.
O. Corrigan (2009)
10.1021/bm801513e
Polysaccharide-based polyelectrolyte complex nanoparticles from chitosan, heparin, and hyaluronan.
Soheil Boddohi (2009)
10.1021/JP075441K
Polysaccharide charge density regulating protein adsorption to air/water interfaces by protein/polysaccharide complex formation.
Renate Antonia Ganzevles (2007)
10.1016/j.jconrel.2009.12.011
Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery.
Hea Eun Lee (2010)
10.1016/j.jconrel.2013.01.027
An intra-articular salmon calcitonin-based nanocomplex reduces experimental inflammatory arthritis.
S. Ryan (2013)
10.1016/J.JCONREL.2005.04.019
Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction.
G. Mayer (2005)
Turksen, Polyelectrolyte-protein complexes
C. L. Cooper (2005)
10.1096/fj.04-2322fje
Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: in vitro and in vivo study
Y. Park (2005)
10.1002/jgm.1352
Hyaluronic acid complexed to biodegradable poly L‐arginine for targeted delivery of siRNAs
Eun-Joong Kim (2009)
10.1211/0022357044085
Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue, Caco‐2 cell lines, and rat jejunum
G. Sandri (2004)
10.1111/j.1472-8206.2008.00633.x
The Hill equation: a review of its capabilities in pharmacological modelling
S. Goutelle (2008)
10.1016/J.COCIS.2005.05.007
Polyelectrolyte-protein complexes
Christy L. Cooper (2005)
10.1016/J.JCONREL.2006.07.016
Incorporation into a biodegradable hyaluronic acid matrix enhances in vivo efficacy of recombinant human interleukin 11 (rhIL11).
A. Takagi (2006)
10.3109/02652048.2011.635426
Salmon calcitonin-loaded Eudragit® and Eudragit®-PLGA nanoparticles: in vitro and in vivo evaluation
Meltem Cetin (2012)
10.1021/BC070111O
Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition.
H. Mok (2007)
10.1093/NAR/28.10.E45
Antisense delivery using protamine-oligonucleotide particles.
M. Junghans (2000)
10.1016/J.EJPB.2005.09.008
Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates.
D. Corrigan (2006)
preparation, structure, properties and applications, Chem
L. Jr. Lapčík (1998)
10.1016/j.ijpharm.2012.07.011
Exploring the assembly process and properties of novel crosslinker-free hyaluronate-based polyelectrolyte complex nanocarriers.
A. Umerska (2012)
10.1002/BIT.10606
Controling the rate of protein release from polyelectrolyte complexes.
N. Kamiya (2003)
10.2307/j.ctvx0787d.4
2 ,
P. Steerenberg (1993)
10.1016/0378-5173(95)04112-5
Adsorption of peptides to poly(D,L-lactide-co-glycolide): 2. Effect of solution properties on the adsorption
Tsuimin Tsai (1996)
10.1016/j.ijpharm.2009.04.009
Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
F. Oyarzun-Ampuero (2009)
10.1021/bm100861g
Rodlike complexes of a polyelectrolyte (hyaluronan) and a protein (lysozyme) observed by SANS.
Isabelle Morfin (2011)
10.1021/BC0501451
Protamine as an efficient membrane-translocating peptide.
F. Reynolds (2005)
10.3109/02652040902751125
Preparation and in vitro–in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles
Eliza Główka (2010)
in vitro and in vivo study, FASEB J
J Y. (2005)



This paper is referenced by
10.1016/j.ijpharm.2018.09.035
Freeze drying of polyelectrolyte complex nanoparticles: Effect of nanoparticle composition and cryoprotectant selection
Anita Umerska (2018)
10.1016/j.ijpharm.2016.04.028
Understanding the adsorption of salmon calcitonin, antimicrobial peptide AP114 and polymyxin B onto lipid nanocapsules.
A. Umerska (2016)
10.1016/j.carbpol.2016.09.035
Design of chondroitin sulfate-based polyelectrolyte nanoplexes: Formation of nanocarriers with chitosan and a case study of salmon calcitonin.
Anita Umerska (2017)
10.3390/pharmaceutics12030259
An Enteric-Coated Polyelectrolyte Nanocomplex Delivers Insulin in Rat Intestinal Instillations When Combined with a Permeation Enhancer
Svenja Sladek (2020)
10.1016/J.JDDST.2017.06.018
Advances on the formulation of proteins using nanotechnologies
Irene Santalices (2017)
10.1016/j.ijpharm.2015.11.042
Synergistic interactions between doxycycline and terpenic components of essential oils encapsulated within lipid nanocapsules against gram negative bacteria.
C. Valcourt (2016)
10.1016/j.carbpol.2017.02.065
Development of a new type of multifunctional fucoidan-based nanoparticles for anticancer drug delivery.
Kun-Ying Lu (2017)
10.1016/j.ijpharm.2014.10.023
Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
A. Umerska (2014)
10.1016/J.JDDST.2017.12.016
Preparation, evaluation and optimization of nanoparticles composed of thiolated triethyl chitosan: A potential approach for buccal delivery of insulin
Marzieh Rahbarian (2018)
10.1007/s11051-015-3121-3
Surface modification of paclitaxel-loaded tri-block copolymer PLGA-b-PEG-b-PLGA nanoparticles with protamine for liver cancer therapy
N. Gao (2015)
10.1371/journal.pone.0189950
Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity
H. Nehme (2018)
10.1002/psc.3176
Protamine‐induced condensation of peptide nanofilaments into twisted bundles with controlled helical geometry
Jiahui Wang (2019)
10.1007/s11051-017-3901-z
Optimisation of the self-assembly process: production of stable, alginate-based polyelectrolyte nanocomplexes with protamine
M. Dul (2017)
10.1016/j.carbpol.2015.01.066
Self-assembled carrageenan/protamine polyelectrolyte nanoplexes-Investigation of critical parameters governing their formation and characteristics.
M. Dul (2015)
10.1111/cbdd.13031
Current state of a dual behaviour of antimicrobial peptides—Therapeutic agents and promising delivery vectors
U. Piotrowska (2017)
10.1142/S0129083518500043
Encapsulated protamine-hyaluronic acid particles for targeting carboplatin directed by radiation
Tomohiro Segawa (2017)
10.1016/j.ejpb.2015.04.006
Chondroitin-based nanoplexes as peptide delivery systems--Investigations into the self-assembly process, solid-state and extended release characteristics.
A. Umerska (2015)
10.1016/j.ejps.2015.04.009
Protamine-oligonucleotide-nanoparticles: Recent advances in drug delivery and drug targeting.
B. Scheicher (2015)
10.1016/j.jconrel.2019.10.052
Enzyme Responsiveness Enhances the Specificity and Effectiveness of Nanoparticles for the Treatment of B16F10 Melanoma.
Y. Huang (2019)
10.1371/journal.pone.0179211
Surface active properties of lipid nanocapsules
Célia Rosemonde Mouzouvi (2017)
10.1016/j.ijpharm.2015.07.008
Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers.
A. Umerska (2015)
10.1016/j.ejpb.2016.09.001
Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
A. Umerska (2016)
Semantic Scholar Logo Some data provided by SemanticScholar